PHR Stock Overview
Phreesia, Inc. ofrece una plataforma integrada de pago y software basada en SaaS para el sector sanitario en Estados Unidos y Canadá.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Phreesia, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$23.74 |
| 52 Week High | US$34.98 |
| 52 Week Low | US$12.05 |
| Beta | 0.92 |
| 1 Month Change | -4.43% |
| 3 Month Change | 1.28% |
| 1 Year Change | -23.84% |
| 3 Year Change | -53.54% |
| 5 Year Change | n/a |
| Change since IPO | -5.34% |
Recent News & Updates
Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Recent updates
Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)
Feb 16
Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth
Jan 04Is Phreesia Finally Turning The Corner?
Dec 07Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?
Oct 25Phreesia: Share Price Dip Is A Buying Opportunity
Sep 21Phreesia: Strong Execution Should Continue To Drive Growth
Jul 11Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion
May 18Phreesia: Strong Growth Momentum With Expanded TAM
Jan 28Phreesia - Healthcare Ecosystem At An Attractive Valuation
Dec 13Phreesia Q3 2023 Earnings Preview
Dec 07Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M
Sep 07Phreesia: Their Time Has Passed
May 10Opportunistic Time To Buy Phreesia's Healthcare Disruption
Dec 27Are Phreesia, Inc. (NYSE:PHR) Investors Paying Above The Intrinsic Value?
Nov 08Is It Time To Consider Buying Phreesia, Inc. (NYSE:PHR)?
Sep 15Phreesia (PHR) Investor Presentation - Slideshow
Jun 16Phreesia, Inc. 2022 Q1 - Results - Earnings Call Presentation
Jun 04Shareholder Returns
| PHR | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 3.8% | -4.0% | -0.7% |
| 1Y | -23.8% | -1.0% | 25.9% |
Rentabilidad frente al sector: PHR obtuvo unos resultados inferiores a los del sector US Healthcare Services , que el año pasado arrojó un rendimiento del 4%.
Rentabilidad vs. Mercado: PHR obtuvo unos resultados inferiores a los del mercado US, que fue del 22.3% el año pasado.
Price Volatility
| PHR volatility | |
|---|---|
| PHR Average Weekly Movement | 6.6% |
| Healthcare Services Industry Average Movement | 10.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: PHR no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de PHR (9%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 1,438 | Chaim Indig | https://www.phreesia.com |
Phreesia, Inc. ofrece una plataforma integrada de software y pagos basada en SaaS para el sector sanitario en Estados Unidos y Canadá. La empresa ofrece soluciones de acceso que incluyen un sistema de programación de citas en línea, recordatorios y gestión de seguimiento de derivaciones; una solución de registro para automatizar el autorregistro de pacientes; una solución de ciclo de ingresos, que ofrece procesos de verificación de seguros, aplicaciones de pago en el punto de venta, cobro de pagos tras la visita y opciones de pago flexibles; y una solución de conexión a la red para ofrecer contenidos clínicamente relevantes a los pacientes. La empresa despliega su plataforma en diversas modalidades, como Phreesia Mobile, un dispositivo móvil para pacientes; Phreesia Dashboard, un panel de control basado en web para clientes de servicios sanitarios; PhreesiaPads, unas tabletas de entrada de autoservicio; y Arrivals Kiosks, unos quioscos in situ.
Phreesia, Inc. Fundamentals Summary
| PHR fundamental statistics | |
|---|---|
| Market cap | US$1.29b |
| Earnings (TTM) | -US$136.88m |
| Revenue (TTM) | US$356.30m |
3.8x
P/S Ratio-9.8x
P/E RatioIs PHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHR income statement (TTM) | |
|---|---|
| Revenue | US$356.30m |
| Cost of Revenue | US$124.01m |
| Gross Profit | US$232.29m |
| Other Expenses | US$369.17m |
| Earnings | -US$136.88m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.43 |
| Gross Margin | 65.19% |
| Net Profit Margin | -38.42% |
| Debt/Equity Ratio | 1.3% |
How did PHR perform over the long term?
See historical performance and comparison